Key facts
- This page summarizes Michael A. Hajost's Form 4 filing for Danimer Scientific, Inc. (DNMRQ).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Feb 2025, 16:30.
Michael A. Hajost - 07 Feb 2025 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- DNMRQ
- Reported as of
- 07 Feb 2025
- Net transaction value
- -$355
- SEC form
- 4
- Accepted by SEC
- 10 Feb 2025, 16:30:05 UTC
- Prior SEC filing
- 05 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen A. Martin, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael A. Hajost filed Form 4 for Danimer Scientific, Inc. (DNMRQ) on 10 Feb 2025.
Change
- Previous filing in this sequence was filed on 05 Apr 2024.
- Current net transaction value: -$355.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNMR
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +859
- Change %
- +48%
- Price
- Shares after
- 2,635
- Date
- 07 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
DNMR
transaction
Class A Common Stock
Tax liability
- Transaction value
- $355
- Shares
- -301
- Change %
- -11%
- Price
- $1.18
- Shares after
- 2,334
- Date
- 07 Feb 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DNMR
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -859
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 07 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 859
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Danimer Scientific Class A common stock.
Footnote F2
On November 12, 2024, the common stock of Danimer Scientific, Inc. reverse split 1 for 40.
Footnote F3
On March 31, 2022, the reporting person was granted 103,092 restricted stock units on a pre-reverse split basis. These awards vested in thirds respectively on February 7, 2023, February 7, 2024 and February 7, 2025.